A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
Conditions: Polymyositis; Dermatomyositis Interventions: Drug: Ustekinumab 6 mg/kg; Drug: Ustekinumab 90 mg; Drug: Placebo IV; Drug: Placebo SC Sponsor: Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2019 Category: Research Source Type: clinical trials
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Conditions: SCAD; Addison Disease; Ankylosing Spondylitis; Antiphospholipid Antibody Syndrome; Celiac Disease; Crohn Disease; Dermatomyositis; Polymyositis; Guillain-Barre Syndrome; Hepatitis, Autoimmune; Graves Disease; Hashimoto Thyroiditis; Multiple Sclerosi s; Myasthenia Gravis; Pernicious Anemia; Polymyalgia Rheumatica; Primary Biliary Cirrhosis; Psoriasis; Rheumatoid Arthritis; Systemic Sclerosis; Sjögren Syndrome; Systemic Lupus Erythematosus; Takayasu Arteritis; Type 1 Diabetes Mellitus; Ulcerative Colitis; Uve...
Source: ClinicalTrials.gov - May 7, 2019 Category: Research Source Type: clinical trials